April - June 2019, Volume 15, Issue 2

Kocak M, Akarsu E, Korkmaz H, Taysi S

The Effect of Antithyroid Drugs on Osteopontin and Oxidative Stress in Graves’ Disease

Acta Endo (Buc) 2019, 15 (2): 221-224
doi: 10.4183/aeb.2019.221

Abstract Objective. The aim of the present study is to evaluate the effects of methimazole (MTZ) and propylthiouracil (PTU) treatments on osteopontin (OPN) and oxidative stress in Graves’ disease (GD). Material and Methods. The study included 60 cases with GD in hyperthyroid state and taking no antithyroid treatment, and 30 healthy volunteers. GD patients were randomly separated into two groups; 30 of them took PTU, and the other 30 took MTZ treatments. Blood samples were taken from the patients with GD before the treatment, and three months after the treatment was begun, when they were in the euthyroid state; blood samples of the healthy control subjects were also taken at these times. Results. TAS and OSI levels before treatment were significantly higher in the GD group, when compared to the control group (p<0.001, for each). GD subjects taking PTU treatment had significantly higher TAS levels (p=0.001), and significantly lower TOS and OSI levels (p=0.008 and p=0.001, respectively). TAS levels significantly decreased in the patients taking MTZ treatment (p=0.029), but TOS and OSI levels did not change significantly (p>0.05). Pretreatment OPN levels were significantly higher in GD patients, when compared to the control group (p=0.014). OPN level significantly decreased in the GD group taking PTU treatment; however OPN levels in the group taking MTZ treatment did not change significantly when compared to the pretreatment value. Conclusion. PTU treatment is more effective in decreasing OPN and oxidative stress in GD patients, when compared to the MTZ treatment.

Keywords: Graves’ disease, oxidative stress, osteopontin, methimazole, propylthiouracil.

Correspondence: Hakan Korkmaz, MD, Suleyman Demirel University, Faculty of Medicine, Department of Internal Medicine, Division of Endocrinology, 32100, Isparta, Turkey, E-mail: drhkorkmaz@yahoo.com.tr